Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery
Publication Date : //
Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis.
The identification of specific protein markers for colorectal cancer would provide the basis for early diagnosis and detection, as well as clues for understanding the molecular mechanisms governing cancer progression. In this report, we describe the proteomic analysis of the samples of colorectal cancer corresponding to seven patients. We have used the highly sensitive two-dimensional differential gel electrophoresis (2-D DIGE) coupled with mass spectrometry (MS) for the identification of proteins differentially expressed in tumoral and neighboring normal mucosa. We have detected differences in abundance of 52 proteins with statistical variance of the tumor versus normal spot volume ratio within the 95th confidence level (Student's t-test; p < 0.05). Forty-one out of 52 analyzed proteins were unambiguously identified by matrix-assisted laser desorption/ionization-time of flight MS coupled with database interrogation as being differentially expressed in colorectal cancer. An ontology analysis of these proteins revealed that they were mainly involved in regulation of transcription (synovial sarcoma X5 protein, metastasis-associated protein 1), cellular reorganization and cytoskeleton (cytokeratins, vimentin, beta actin), cell communication and signal transduction (annexins IV and V, relaxin, APC), and protein synthesis and folding (heat shock protein 60, calreticulin, cathepsin D, RSP4) among others. Preliminary studies demonstrated that the differentially expressed proteins found by 2-D DIGE could be confirmed and validated by immunoblotting and immunohistochemistry analyses in those few cases where antibodies were available. We believe that the incorporation of more samples and new datasets will permit the definition of a collection of proteins with a potential interest as biomarkers for colorectal cancer.
Authors : Alfonso Patricia , Núñez Antonio , Madoz-Gurpide Juan , Lombardia Luis , Sánchez Lydia , Casal J Ignacio ,
Related products :
52062 Aachen Deutschland
Support Karolina Elandt
Tel: +49 0241 40 08 90 86, +49 0241 95 78 94 78, +49 0241 40 08 90 86
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
[email protected] | Gentaur | Gentaur
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Finland Helsset +358942419041
Magyarország Budapest +3619980547
US New York+17185132983
WP2256: Integrated Pancreatic Cancer Pathway
WP2335: sGC Cancer
WP1263: Mitochondrial Gene Expression
WP2367: Private Pancreatic Cancer
WP2429: Cancer prevention Q
WP1589: Folate-Alcohol and Cancer Pathway
WP1968: genetic alternations of lung cancer
WP2107: pathways in human cancer
WP2291: Deregulation of Rab and Rab Effector Genes in Bladder Cancer
WP2363: Gastric cancer network 2
WP1368: Mitochondrial Gene Expression
WP2411: Cancer prevention Q
WP928: Mitochondrial Gene Expression
WP1963: The effect of Glucocorticoids on target gene expression
WP1984: Integrated Breast Cancer Pathway
WP2263: Prostate Cancer
WP2361: Gastric cancer network 1
WP1301: Mitochondrial Gene Expression
WP2377: Integrated Pancreatic Cancer Pathway
WP391: Mitochondrial Gene Expression
WP1821: Gene Expression
WP1971: Integrated Cancer pathway
Related Genes :
 Poly(C)-binding protein 1 mediates drug resistance in colorectal cancer.
 Identification of actin beta-like 2 (ACTBL2) as novel, upregulated protein in colorectal cancer.
 Proteomic characterization of peroxisome proliferator-activated receptor-γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype.
 Predicting response to vascular endothelial growth factor inhibitor and chemotherapy in metastatic colorectal cancer.
 Proteomic analysis shows down-regulations of cytoplasmic carbonic anhydrases, CAI and CAII, are early events of colorectal carcinogenesis but are not correlated with lymph node metastasis.
 Differential proteomics identifies PDIA3 as a novel chemoprevention target in human colon cancer cells.
 Rho GDP-dissociation inhibitor alpha is associated with cancer metastasis in colon and prostate cancer.
 Proteomic analysis of colorectal cancer metastasis: stathmin-1 revealed as a player in cancer cell migration and prognostic marker.
 Analysis of differentially expressed proteins in colorectal cancer using hydroxyapatite column and SDS-PAGE.
 Proteomic analysis of advanced colorectal cancer by laser capture microdissection and two-dimensional difference gel electrophoresis.
Enter catalog number :